BCL2 and neoplasm: CECs expressing Bcl-2 in the patient blood samples might be originating from tumor microvasculature and their binding to tumor cells induces a marked increase in Src and FAK activation in tumor cells, with anchorage independent survival (222), inhibition of both apoptosis, through regulating Bim, and anoikis, through regulating BAD (223, 224).